Want to join the conversation?
$CMI's sales in Distribution segment for 1Q16 slid by 1%, as increased revenue from acquisitions and growth in international markets were more than offset by lower sales in off-highway markets in North America and negative impact of currency. Components sales fell 5% on lower sales in North America and unfavorable impact of currency.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.